We are pleased to announce that the Controlled Release Society (CRS) has announced the election of Paolo Colombo, Pharm. D., Ph.D., CEO of PlumeStars, Emeritus Professor, Department of Food and Drug, University of Parma, Italy to its College of Fellows.
Read more “PAOLO COLOMBO ELECTED INTO CONTROLLED RELEASE SOCIETY (CRS) COLLEGE OF FELLOWS”
PlumeSTARS srl, the start up at University of Parma, received a new financial funding within the Horizon 2020 program. In the last round of the EIC SME-Instrument Phase 1 – cut off of 13 February 2019 – 277 small and medium-sized enterprises from 25 EU countries have been selected for funding. PlumeSTARS is one of them.
PlumeSTARS got a contribution of 50,000 euros for preparing the Business Plan of its Orphan Medicine Hyalcis. The productis a Polymeric biodegradable film, loaded with cisplatin drug, the active substance for cancer treatment. The film, developed and tested in collaboration with the Department of Medicine & Surgery (Prof Paolo Carbognani) and Department Food & Drug (Prof. Fabio Sonvico) of the University of Parma, is proposed to be implanted in the thoracic surface after the removal of primary tumor in the pleural mesothelioma cancer. The product, already tested in animals, obtained the Orphan medicine designation and is on way for studies in human trials, with the goal of market authorization application.
Most of the selected SME-Instrument candidates are active in the ICT, health and engineering sectors: the beneficiary companies come from Spain (46), Switzerland (23) and France (22). 21 Italian companies are beneficiaries, including PlumeStars srl.
The SME- Instrument program is part of the European Innovation Council (EIC) pilot project, which supports high-level innovators, entrepreneurs, small businesses and scientists with funding opportunities and acceleration services.
Eride Quarta, PhD student in “Drugs, Biomolecules and Health Products“ of the University of Parma, coordinator Prof. Marco Mor, received the “Best Poster Award” Award, at the EUFEPS Annual Meeting 2019, held in Frankfurt, Germany, 6-8 March 2019.
The award was given for the presentation of the research “Pulmonary administration of a novel insulin powder in comparison to Afrezza”, carried out in collaboration with Prof. Francesca Buttini and Prof. Paolo Colombo and Prof. Elisabetta Barocelli, of the Department of Pharmaceutical and Food Sciences of the University of Parma.
Read more “To Dr Eride Quarta the “Best Poster Award” at the European Federation for Pharmaceutical Sciences Annual meeting”
In occasion of the Annual Conference of the European Association of Pharmacy 2018: 16-18 May, Parma, Italy, the Food and Drug Department of the University of Parma, in collaboration with the Innovative SME PlumeSTARS, announces the organization of the Pre-Conference Workshop Medicines for rare diseases, Wednesday, May 16th, 2018, Aula Magna, Via Università 12, Parma, Italy.
Read more “May 16th 2018: Pre-Conference Workshop “Medicines for rare diseases”, in collaboration with University of Parma”
On Friday, November 10, at the Aula Magna of the University of Parma (Via Università 12), the meeting “Malignant pleural mesothelioma: preclinical and clinical research” will take place.
Read more “Conference “Malignant pleural mesothelioma: preclinical and clinical research” in Parma”
On Friday, July 21, 2017, a Framework Agreement has been signed between the University of Parma and PlumeStars s.r.l. concerning a didactic and scientific collaboration between the Food and Drug Department and the start up PlumeStars.
Read more “Signed the Framework Agreement between the University of Parma and PlumeStars s.r.l.”